Fabino Enterprises Ltd

FABINOPharmaceuticals & Biotechnology
13.98+0.00 (+0.00%)
As on 29 Jan 2026, 10:35 amMarket Closed

Fundamental Score

...

Fabino Enterprises Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

1.44%
Poor

Return on Capital Employed

5.61%

Operating Profit Margin (5Y)

N/A
Poor

Dividend Yield

0.00%

Valuation Metrics

Poor

Price to Earnings

84.83x

Market Capitalization

5.09 (Cr)

Industry P/E

33.97x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

160.00%
Excellent

YoY Quarterly Sales Growth

67.64%

Sales Growth (5Y)

N/A

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Financial Health

Good

Debt to Equity

0.43x
Poor

Interest Coverage

2.46x

Free Cash Flow (5Y)

N/A

Ownership Structure

Good

Promoter Holding

56.82%
Poor

FII Holding

0.00%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
56.82%
Promoter Holding
5.09 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of FABINO across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Robust Profit Growth (160.00%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (67.64%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Balanced Promoter Holding (56.82%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

9 factors identified

Below-Average Return on Equity (1.44%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (5.61%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.

Premium Valuation Risk (P/E: 84.83x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.

Weak Interest Coverage (2.46x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

Very Low ROE

Observation: Poor capital utilization and shareholder returns.

Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Very High P/E Ratio

Observation: Significant overvaluation risk present.

Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Financial Statements

Comprehensive financial data for Fabino Enterprises Ltd

About FABINO

Business Overview

Fabino Enterprises Limited manufactures, markets, trades, and packages pharmaceutical and other wellness focused consumer products in India. It offers tablets, ointments syrups, etc. for various medical treatments in allopathic and certain herbal categories as well as food and wellness products under the Fabino and Keepshine brand names. The company also exports wellness and FMCG products, such as coffee, malt powder, protein powder, and hair shampoo. It markets its products through its own distribution network and sales force. The company was formerly known as Fabino Life Sciences Limited and changed its name to Fabino Enterprises Limited in June 2024. Fabino Enterprises Limited was incorporated in 2011 and is based in Sonipat, India.

Company Details

Symbol:FABINO
Industry:Pharmaceuticals & Biotechnology
Sector:Pharmaceuticals

Key Leadership

Mr. Aditya Mahavir Jain
MD & Chairman
Mr. Pankaj Jain
Chief Financial Officer
Mr. Anand Katarmal
Company Secretary & Compliance Officer

FABINO Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)1.44%
Return on Capital Employed5.61%
Operating Profit Margin (5Y)N/A%
Debt to Equity Ratio0.43
Interest Coverage Ratio2.46

Growth & Valuation

Sales Growth (5Y)N/A%
Profit Growth (5Y)N/A%
EPS Growth (5Y)N/A%
YoY Quarterly Profit Growth160.00%
YoY Quarterly Sales Growth67.64%

Frequently Asked Questions

What is the current price of Fabino Enterprises Ltd (FABINO)?

As of 29 Jan 2026, 10:35 am IST, Fabino Enterprises Ltd (FABINO) is currently trading at ₹13.98. The stock has a market capitalization of ₹5.09 (Cr).

Is FABINO share price Overvalued or Undervalued?

FABINO is currently trading at a P/E ratio of 84.83x, compared to the industry average of 33.97x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.

What factors affect the Fabino Enterprises Ltd share price?

Key factors influencing FABINO's price include its quarterly earnings growth (Sales Growth: 67.64%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Fabino Enterprises Ltd a good stock for long-term investment?

Fabino Enterprises Ltd shows a 5-year Profit Growth of N/A% and an ROE of 1.44%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.43 before investing.

How does Fabino Enterprises Ltd compare with its industry peers?

Fabino Enterprises Ltd competes with major peers in the Pharmaceuticals & Biotechnology. Investors should compare FABINO's P/E of 84.83x and ROE of 1.44% against the industry averages to determine its competitive standing.

What is the P/E ratio of FABINO and what does it mean?

FABINO has a P/E ratio of 84.83x compared to the industry average of 33.97x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹85 for every ₹1 of annual earnings.

How is FABINO performing according to Bull Run's analysis?

FABINO has a Bull Run fundamental score of 32/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does FABINO belong to?

FABINO operates in the Pharmaceuticals & Biotechnology industry. This classification helps understand the competitive landscape and sector-specific trends affecting Fabino Enterprises Ltd.

What is Return on Equity (ROE) and why is it important for FABINO?

FABINO has an ROE of 1.44%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Fabino Enterprises Ltd generates profits from shareholders' equity.

How is FABINO's debt-to-equity ratio and what does it indicate?

FABINO has a debt-to-equity ratio of 0.43, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.

What is FABINO's dividend yield and is it a good dividend stock?

FABINO offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has FABINO grown over the past 5 years?

FABINO has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.

What is the promoter holding in FABINO and why does it matter?

Promoters hold 56.82% of FABINO shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is FABINO's market capitalization category?

FABINO has a market capitalization of ₹5 crores, placing it in the Small-cap category.

How volatile is FABINO stock?

FABINO has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for FABINO?

FABINO has a 52-week high of ₹N/A and low of ₹N/A.

What is FABINO's operating profit margin trend?

FABINO has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.

How is FABINO's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 67.64% and YoY Profit Growth of 160.00%.

What is the institutional holding pattern in FABINO?

FABINO has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.